AUTL Autolus Therapeutics plc
Healthcare$1.68-1.18%ClosedMarket Cap: $447.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.11
P/S
4.83
EV/EBITDA
-1.60
DCF Value
$-27.43
FCF Yield
-65.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
-11.2%
Operating Margin
-285.9%
Net Margin
-312.0%
ROE
-128.5%
ROA
-54.8%
ROIC
-56.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $26.2M | 6.3% | $-59.5M | $-71.6M | $— | — |
| Q4 null | $24.3M | -4.3% | $-72.4M | $-90.2M | $— | — |
| FY null | $75.6M | -27.8% | $-281.4M | $-288.2M | $— | — |
| Q3 null | $21.2M | -35.1% | $-71.6M | $-79.1M | $— | — |
| Q2 null | $20.9M | -16.8% | $-61.2M | $-47.9M | $— | — |
| Q1 null | $9.0M | -99.9% | $-65.2M | $-70.2M | $— | — |
| Q4 null | $29.0K | -476810.3% | $-241.4M | $-27.6M | $— | — |
| FY null | $10.1M | -1293.5% | $-241.4M | $-220.7M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-68.9M | $-82.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-58.9M | $-58.3M | $— | — |
| Q1 null | $10.1M | 82.1% | $-38.8M | $-52.7M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-40.9M | $-77.2M | $-0.44 | — |